Skip to Content
Manchester Metropolitan University Library
Medicines As a Service: Nnew Commercial Model for Big Pharma in the Postblockbuster World

Medicines As a Service: Nnew Commercial Model for Big Pharma in the Postblockbuster World

Mattke, Soeren; Mengistu, Tewodaj; Klautzer, Lisa

The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. Our argument is based on the fact that, although effective medicines for most chronic conditions exist, access and adherence to medicines are far from what would be needed to achieve full treatment efficacy. Therefore, value can be created by getting and keeping more patients on their drugs, and innovative business models would allow pharmaceutical companies to capture that value

eBook, Electronic resource, Book. English. Electronic books.
Published Santa Monica, CA : RAND Health 2012

This resource is available electronically from the following locations


Statement of responsibility: Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu
ISBN: 0833076469, 9780833076465
Note: Includes bibliographical references.
Note: Title from PDF caption.
Note: Version viewed Sept. 9, 2014.
Physical Description: 1 online resource (1 PDF file (11 pages)).
Series: Occasional paper
Subject: Pharmaceutical industry.; Developing Countries.; Pharmaceutical services.; Models, Theoretical.; Drug Industry economics.; MEDICAL Pharmacology.; Chronic Disease drug therapy.; Medication Adherence.
Series Title: Occasional paper (Rand Corporation)
Local note: JSTOR Books at JSTOR Open Access


  1. Medicines as a Service.